Nick is the Wellcome Trust Observer on the Stevenage Bioscience Catalyst Board.

At Wellcome, Nick is Head of the Priority Area, team with responsibility for a broad portfolio of translational projects across the pharmaceutical and life sciences sector. He is responsible for the discovery & development activities at UK and US R&D hubs across a broad range of disease areas, including creative external partnerships with academia, venture capital firms and incubators. Nick has built a successful portfolio of discovery and clinical assets at all stages of development.

Nick has significant global experience in discovering and developing impactful medicines including ten years at GSK.  Previously, Nick has also pioneered the open innovation agenda in diseases of the developing world and the establishment of the Tres Cantos Open Lab Foundation supporting novel neglected disease drug discovery ideas at the academic-industry interface.